Diffuse-type Gastric Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-02
Clinical Trial Update: QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer [Phase 2]
A Phase 2 trial is evaluating QL1706-SOX versus SOX alone as neoadjuvant therapy for resectable diffuse-type gastric cancer (gastric cancer,…